Answer
The safety and efficacy of Piqray (alpelisib) in children aged 0–18 years have not been established, and no data are available.
Sources for this answer
- Piqray 50 mg, 150 mg and 200 mg film-coated tabletsNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.2 Posology and method of administration · Version 12Document updated
Sources checked